The future of biomarkers in toxicology is promising, with advances in technology and molecular biology paving the way for more precise and comprehensive biomarkers. Innovations such as omics technologies (genomics, proteomics, metabolomics) are expected to enhance the understanding of complex biological responses to toxicants. These advancements will likely lead to the discovery of novel biomarkers that can provide deeper insights into exposure, effect, and susceptibility, ultimately improving risk assessment and public health protection.
In conclusion, biomarkers are indispensable tools in toxicology, offering valuable insights into the interactions between chemicals and biological systems. While there are challenges in their development and application, ongoing research and technological advancements hold great promise for their future use in advancing our understanding of toxicological risks and improving health outcomes.
